SB-525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6.
The TGF-β pathway regulates a wide variety of cellular processes in many different cell types and biological contexts. There are three identified TGF receptor ligands, TGF-β1, 2, and 3. Activated TGF-β ligands can interact with TGF-β type II receptors (TβRII), then recruit and phosphorylate the TGF-β type I receptors (also called as TβRI or ALK5). In turn, activated TβRI phosphorylates SMAD2 and SMAD3 at C-terminal serine residues. Following that, phosphorylated SMAD and SMAD3 assemble into heterodimeric and trimeric complexes with SMAD4. Then the trimeric complex translocate into the nucleus and regulate the expression of TGF-β target genes[1]. SB-525334 is an ALK5 inhibitor with IC50 value of 14.3 nM, with modest potent to ALK4 with an IC50 value of 58.5 nM (measured by GST-ALKs kinase assay). Addition of 1 μM SB-525334 reduced TGF-β1-induced Smad2 and Smad3 nuclear localization back to the control levels in RPTE cells[2]. SB-525334 on concentration of 0.5 - 2 μM can inhibit p-SMAD2 in dose-dependent manner in ELT-3 cells[3]. SB525334, 30 mg/kg, given twice daily by oral gavage for 2 weeks can attenuate f bleomycin-induced lung fibrosis in mice[4].
SB-525334 细胞研究
细胞系
浓度
检测类型
检测时间
活动说明
数据源
AsPC1
0-10 μM
Cell Viability Assay
72 h
efficiently reduces the viability with gemcitabine
22399597
ELT-3
0.5/1.0/2.0 μM
Function Assay
1 h
inhibits TGF-β signaling in leiomyomas
17505012
HUVECs
10 μM
Function Assay
24/48/72 h
leads to a disruption of the HUVEC monolayer after 72 hr
搜索
